CR1 and Alzheimer disease: Although this study provides numerous clues, the precise mechanism by which enhanced opsonic phagocytosis confers AD risk, and the impact of other AD risk variants in CR1, for example the coding variant in LHR‐D implicated in binding Αβ and C1q,49 remain to be elucidated.